Cardioneuroablation for Bradyarrhythmia

Exclusion Criteria

• •1. Anamnesis of injury during syncopation due to bradycardia, except in the case when the patient refused to implant an electrocardiostimulator for his own reasons in writing;
• •2. Constant intake of antiarrhythmic drugs (for PVC, AF, etc.);
• •3. The presence of an implanted pacemaker, a heart contractility modulation device, a cardioverter defibrillator;
• •4. Drug-induced sinus bradycardia and/or atrioventricular block;
• •5. Bradycardia due to electrolyte imbalance (e.g. hyperkalemia);
• •6. Bradycardia due to hypothyroidism or other reversible conditions;
• •7. No reaction to the administration of atropine (up to a maximum dose of 0.2 mg / kg);
• •8. Proven association of bradyarrhythmia with episodes of apnea/hypopnea in obstructive sleep apnea syndrome;
• •9. Clinically significant coronary artery disease;
• •10. Postinfarction cardiosclerosis;
• •11. Hemodynamically significant congenital heart defects, including operated ones;
• •12. Stroke or transient ischemic attack \<3 months;
• •13. Open heart surgery in the anamnesis;
• •14. Catheter interventions on coronary arteries or for cardiac arrhythmias \<3 days;
• •15. Conditions after percutaneous coronary angioplasty \<3 months;
• •16. Anamnesis of stable ventricular tachycardia on the background of bradycardia;
• •17. Pregnancy or breastfeeding period